Education
About Us
Working with TipRanks
Follow Us
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
ASTRAZEN Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹6,222.35 - ₹10,653.05
Previous CloseN/A
Volume65.42K
Average Volume (3M)3.08K
Market Cap
₹227.77B
Enterprise Value₹48.54B
Total Cash (Recent Filing)₹4.97B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)196.8
Beta0.69
Next Earnings
Aug 11, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 18, 2025Dividend Yield0.35%
Share Statistics
EPS (TTM)23.30
Shares Outstanding25,000,000
10 Day Avg. Volume2,142
30 Day Avg. Volume3,081
Financial Highlights & Ratios
PEG Ratio1.29
Price to Book (P/B)18.26
Price to Sales (P/S)0.00
P/FCF Ratio759.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AstraZeneca Pharma India Limited News
PremiumCompany Announcements
AstraZeneca Pharma India Confirms Regulatory Compliance
PremiumCompany Announcements
AstraZeneca Pharma India Sets Record Date for Final Dividend
PremiumCompany Announcements
AstraZeneca Pharma India to Discontinue Imdur Production
PremiumCompany Announcements
AstraZeneca Pharma India Faces Draft Order on Transfer Pricing IssuesASTRAZEN FAQ
What was AstraZeneca Pharma India Limited’s price range in the past 12 months?
AstraZeneca Pharma India Limited lowest stock price was ₹6222.35 and its highest was ₹10653.05 in the past 12 months.
What is AstraZeneca Pharma India Limited’s market cap?
AstraZeneca Pharma India Limited’s market cap is ₹227.77B.
When is AstraZeneca Pharma India Limited’s upcoming earnings report date?
AstraZeneca Pharma India Limited’s upcoming earnings report date is Aug 11, 2025 which is in 22 days.
How were AstraZeneca Pharma India Limited’s earnings last quarter?
Currently, no data Available
Is AstraZeneca Pharma India Limited overvalued?
According to Wall Street analysts AstraZeneca Pharma India Limited’s price is currently Overvalued.
Does AstraZeneca Pharma India Limited pay dividends?
AstraZeneca Pharma India Limited pays a Annually dividend of ₹32 which represents an annual dividend yield of 0.35%. See more information on AstraZeneca Pharma India Limited dividends here
What is AstraZeneca Pharma India Limited’s EPS estimate?
AstraZeneca Pharma India Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AstraZeneca Pharma India Limited have?
AstraZeneca Pharma India Limited has 25,000,000 shares outstanding.
What happened to AstraZeneca Pharma India Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AstraZeneca Pharma India Limited?
Currently, no hedge funds are holding shares in IN:ASTRAZEN
Company Description
AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brands; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brands. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Technical Analysis
Alkem Laboratories Ltd.
―
GlaxoSmithKline Pharmaceuticals Limited
―
Glenmark Pharmaceuticals Limited
―